Skip to main content
. 2020 Mar 31;11(13):3713–3716. doi: 10.7150/jca.39265

Figure 2.

Figure 2

Effect of lovastatin, HER2 inhibitor and HER1 inhibitor on the cell viability of TNBC CSCs. MDA-MB-231 CSCs were treated with different concentrations of LV, TAK 165 (HER2 inhibitor) and/or AG 1478 (HER1 inhibitor) for 72 h. The cell viability was detected by AlamarBlue assay. Combination index (CI) was calculated using the CompuSyn software. CI < 1.0 (#) indicated a synergistic effect.